Výše uvedená léčba kyselinou alendronovou a risedronovou je dlouhodobá, minimálně po dobu jednoho roku. Terapie delší než jeden rok je indikována pouze pokud u pacienta prokazatelně zastavila úbytek kostní hmoty.
| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 225,58 | P |
| 93985 | LODRONAT | cps 60x500mg | BOM | A |
| 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF |
| 56638 | BONEFOS 800MG | tbl obd 60x800mg | LOY | SF |
| 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 41,30 | P |
| 356.3 | M05BA07 | kyselina risedronová | p.o. | 1 | DF | 39,40 | P |
| 357 | M05BA | bisfosfonáty | parent. | O/P |
Destrukce kosti a hyperkalcémie provázející zhoubné nádory s kostními metastázami nebo bez nich; mnohočetný myelom.
Výše uvedená léčba kyselinou alendronovou je dlouhodobá, minimálně po dobu jednoho roku. Terapie delší než jeden rok je indikována pouze pokud u pacienta prokazatelně zastavila úbytek kostní hmoty.
| 357.1 | M05BA02 | kyselina klodronová | parent. | 1.5 | GM | 2348,73 | O/P |
| 94548 | BONEFOS | inj 5x5ml 60mg/ml | STF | SF |
| 93972 | LODRONAT | inj 5x10ml | BOM | A |
| 57452 | LODRONAT AMPULE | inj 5x10ml | BOM | D |
| 357.2 | M05BA03 | kyselina pamidronová | parent. | 60 | MG | 3758,01 | O/P |
| 357.3 | M05BA06 | kyselina ibandronová | parent. | 2 | MG | 9384,77 | O/P |
| 358 | N01AA | inhalační anestetika ze skupiny etherů | inhal. | H |
| 358.1 | N01AA01 | ether pro anestézii (diethylether) | inhal. | 100 | GM | 15,45 | H |
| 359 | N01AB | inhalační anestetika ze skupiny halogenovaných uhlovodíků | inhal. | H |
| 359.1 | N01AB01 | halotan | inhal. | 100 | ML | 304,96 | H |
| 75284 | NARCOTAN | liq 1x250ml | LEX | CZ |
| 359.2 | N01AB06 | isofluran | inhal. | 100 | ML | 2290,62 | H |
| 359.3 | N01AB08 | sevofluoran | inhal. | 100 | ML | 2290,62 | H |
| 360 | N01AF | injkeční anestetika ze skupiny barbiturátů | parent. | H |
| 360.1 | N01AF01 | metohexital | parent. | 0.5 | GM | 142,63 | H |
| 360.2 | N01AF03 | thiopental (do 500 mg v jedné ampuli včetně) | parent. | 0.5 | GM | 60,41 | H |
| 97388 | THIOPENTAL VUAB | inj sic 1x500mg | VUA | CZ |
| 360.3 | N01AF03 | thiopental (nad 500 mg v jedné ampuli) | parent. | 0.5 | GM | 37,10 | H |
| 97389 | THIOPENTAL VUAB | inj sic 1x1gm | VUA | CZ |
| 361 | N01AH | opioidní anestetika (fentanyl) | parent. | O |
| 361.1 | N01AH01 | fentanyl (nad 2 ml roztoku v ampuli) | parent. | 1 | MG | 119,41 | O |
| 01449 | FENTANYL | inj 50x10ml/0.5mg | JAN | B |
| 60911 | FENTANYL | inj 5x10ml/0.5mg | JAN | B |
| 361.2 | N01AH01 | fentanyl (do 2 ml roztoku v ampuli včetně) | parent. | 1 | MG | 173,62 | O |
| 76527 | FENTANYL | inj 50x2ml/0.1mg | JAN | B |
| 362 | N01AH | opioidní anestetika (ostatní) | parent. | H |
| 362.1 | N01AH02 | alfentanyl | parent. | 1.5 | MG | 48,29 | H |
| 87721 | RAPIFEN | inj 5x2ml | JAN | B |
| 362.2 | N01AH03 | sufentanyl (do 10 RG v ampuli včetně) | parent. | 0.6 | MG | 1383,67 | H |
| 93701 | SUFENTA I.V. | inj 5x2ml/10rg | JAN | B |
| 362.3 | N01AH03 | sufentanyl (nad 50 RG v ampuli) | parent. | 0.6 | MG | 740,22 | H |
| 93702 | SUFENTA FORTE I.V. | inj 5x5ml/250rg | JAN | B |
| 362.4 | N01AH03 | sufentanyl (nad 10 do 50 RG v ampuli včetně) | parent. | 0.6 | MG | 1210,83 | H |
| 85526 | SUFENTA FORTE I.V. | inj 5x1ml/50rg | JAN | B |
| 93703 | SUFENTA I.V. | inj 5x10ml/50rg | JAN | B |
| 362.5 | N01AH51 | fentanyl v kombinacích | parent. | 4 | ML | 38,22 | H |
| 362.6 | N01AH06 | remifentanyl | parent. | 1 | MG | 264,29 | H |
| 56741 | ULTIVA 5MG | inj sic 5x5mg | GWE | GB |
| 56740 | ULTIVA 2MG | inj sic 5x2mg | GWE | GB |
| 363 | N01AX | ostatní celková anestetika | parent. | O |
| 363.1 | N01AX03 | ketamin (koncetrace do 1 % včetně) | parent. | 100 | ML | 240,19 | O |
| 64824 | NARKAMON 1% INJ. | inj 10x10ml/100mg | SPX | CZ |
| 363.2 | N01AX03 | ketamin (koncentrace nad 1%) | parent. | 10 | ML | 117,02 | O |
| 363.3 | N01AX04 | propanidid | parent. | 1 | GM | 32,11 | O |
| 363.4 | N01AX07 | etomidát | parent. | 50 | MG | 162,72 | O |
| 363.5 | N01AX10 | propofol | parent. | 10 | ML | 96,14 | O |
| 53441 | PROPOFOL ABBOTT | inj 5x20ml/200mg-am | ABN | USA |
| 53442 | PROPOFOL ABBOTT | inj 5x20ml/200mg-la | ABN | USA |
| 53443 | PROPOFOL ABBOTT | inj 1x50ml/500mg | ABN | USA |
| 53444 | PROPOFOL ABBOTT | inj 1x100ml/1gm | ABN | USA |
| 364 | N01BA | lokální anestetika ze skupiny esterů kyseliny aminobenzoové | parent. | O |
| 364.1 | N01BA | estery aminobenzoové kyseliny | parent. | 100 | ML | 19,55 | O |
| 364.2 | N01BA02 | prokain (do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
| 00564 | PROCAIN LECIVA 1% | inj 10x5ml 1% | LEX | CZ |
| 00565 | PROCAIN LECIVA 1% | inj 10x10ml 1% | LEX | CZ |
| 364.3 | N01BA02 | prokain (nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,54 | O |
| 69669 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x80ml 0.2% | ARD | CZ |
| 69670 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x250ml 0.2% | ARD | CZ |
| 69671 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x500ml 0.2% | ARD | CZ |
| 69673 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ |
| 69674 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ |
| 69676 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x250ml 1% | ARD | CZ |
| 69677 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x500ml 1% | ARD | CZ |
| 86437 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 40x80ml 0.2% | ARD | CZ |
| 86444 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x250ml 0.2% | ARD | CZ |
| 86445 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 12x500ml 0.2% | ARD | CZ |
| 86447 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ |
| 86448 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ |
| 86450 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 20x250ml 1% | ARD | CZ |
| 86451 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 12x500ml 1% | ARD | CZ |
| 89212 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 1x200ml 0.2% | ARD | CZ |
| 89213 | INJECTIO PROCAIN.CHLOR.0.2% ARD | inj 20x200ml 0.2% | ARD | CZ |
| 89214 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 1x200ml 0.5% | ARD | CZ |
| 89215 | INJECTIO PROCAIN.CHLOR.0.5% ARD | inj 20x200ml 0.5% | ARD | CZ |
| 89216 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 1x200ml 1% | ARD | CZ |
| 89217 | INJECTIO PROCAIN.CHLOR.1% ARD. | inj 20x200ml 1% | ARD | CZ |
| 365 | N01BB | lokální anestetika ze skupiny amidů | lok. | O |
| 365.1 | N01BB | trimekain | lok. | 1 | GM | 1,22 | O |
| 02684 | MESOCAIN | gel 1x20gm | SLO | SK |
| 365.2 | N01BB02 | lidokain | lok. | 1 | ML | 7,68 | O |
| 62393 | INSTILLAGEL | gel 10x11 ml(strik.) | FAP | D |
| 366 | N01BB | lokální anestetika ze skupiny amidů | parent. | O |
| 366.1 | N01BB | trimekain (koncentrace 0,5%) | parent. | 1 | ML | 0,73 | O |
| 69704 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x80ml 0.5% | ARD | CZ |
| 69705 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x250ml 0.5% | ARD | CZ |
| 69706 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 1x500ml 0.5% | ARD | CZ |
| 86452 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 40x80ml 0.5% | ARD | CZ |
| 86453 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 20x250ml 0.5% | ARD | CZ |
| 86454 | INJECTIO TRIMECAIN.CHL.0.5% ARD | inj 12x500ml 0.5% | ARD | CZ |
| 366.2 | N01BB | trimekain (koncentrace 1%, do 10 ml v jedné ampuli včetně) | parent. | 1 | ML | 1,37 | O |
| 00502 | MESOCAIN | inj 10x10ml 1% | LEX | CZ |
| 366.3 | N01BB | trimekain (koncentrace 1%, nad 10 ml v jedné ampuli) | parent. | 1 | ML | 0,78 | O |
| 69707 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x80ml 1% | ARD | CZ |
| 69708 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x250ml 1% | ARD | CZ |
| 69709 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 1x500ml 1% | ARD | CZ |
| 86455 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 40x80ml 1% | ARD | CZ |
| 86456 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 20x250ml 1% | ARD | CZ |
| 86457 | INJECTIO TRIMECAIN.CHL.1% ARD. | inj 12x500ml 1% | ARD | CZ |
| 366.4 | N01BB | trimekain (koncentrace 2%) | parent. | 1 | ML | 1,22 | O |
| 00503 | MESOCAIN | inj 10x5ml 2% | LEX | CZ |
| 366.5 | N01BB | trimekain/adrenalin | parent. | 1 | ML | 2,35 | O |
| 366.6 | N01BB01 | bupivakain | parent. | 1 | ML | 3,52 | O |
| 366.7 | N01BB01 | bupivakain (lékové formy spinal) | parent. | 1 | ML | 49,66 | O |
| 92836 | MARCAINE SPINAL 0.5% HEAVY | inj 5x4ml/20mg | AST | S |
| 366.8 | N01BB02 | lidokain | parent. | 1 | ML | 1,22 | O |
| 366.9 | N01BB03 | mepivakain | parent. | 1 | ML | 3,52 | O |
| 366.10 | N01BB08 | artikain | parent. | 1 | ML | 4,15 | O |
| 08751 | ULTRACAIN 2% | inj 5x5ml | HOE | D |
| 366.11 | N01BB08 | artikain (lékové formy hyperbar) | parent. | 1 | ML | 10,22 | O |
| 91234 | ULTRACAIN HYPERBAR 5% | inj 10x2ml/100mg | HOE | D |
| 366.12 | N01BB51 | bupivakain/adrenalin | parent. | 1 | ML | 3,81 | O |
| 366.13 | N01BB52 | lidokain/adrenalin | parent. | 1 | ML | 2,35 | O |
| 366.14 | N01BB58 | artikain/adrenalin | parent. | 1 | ML | 4,15 | O |
| 93109 | SUPRACAIN 4% | inj 10x2ml | LEX | CZ |
| 366.15 | N01BB09 | ropivacain | parent. | 1 | ML | 15,64 | O |
| 56038 | NAROPIN 2MG/ML | inj 5x10ml/20mg | APN | S |
| 367 | N01BX | ostatní lokální anestetika | lok. | O |
| 367.1 | N01BX01 | ethylchlorid | lok. | 100 | ML | 93,36 | O |
| 368 | N02AA | analgetika ze skupiny přírodních opioidů | p.o. |
| 368.1 | N02AA01 | morfin (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 79,40 |
| 55939 | M-ESLON SR 10 | cps ret 50x10mg | ETP | F |
| 55940 | M-ESLON SR 10 | cps ret 100x10mg | ETP | F |
| 80405 | VENDAL RETARD | tbl fc 30x10mg | LAR | D |
| 88834 | M-ESLON SR 10 | cps ret 20x10mg | ETP | F |
| 94309 | MST CONTINUS | tbl 60x10mg | NPP | GB |
| 368.2 | N02AA01 | morfin (nad 10 mg do 30 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 53,20 |
| 12919 | SLOVALGIN 30 RETARD | tbl obd 10x30mg | SLO | SK |
| 47265 | SLOVALGIN 30 RETARD | tbl obd 60x30mg | SLO | SK |
| 55941 | M-ESLON SR 30 | cps ret 50x30mg | ETP | F |
| 55942 | M-ESLON SR 30 | cps ret 100x30mg | ETP | F |
| 80406 | VENDAL RETARD | tbl fc 30x30mg | LAR | D |
| 88835 | M-ESLON SR 30 | cps ret 20x30mg | ETP | F |
| 94310 | MST CONTINUS | tbl 60x30mg | NPP | GB |
| 368.3 | N02AA01 | morfin (100 a více mg v jedné tabletě) | p.o. | 0.1 | GM | 46,55 |
| 46975 | SLOVALGIN 100 RETARD | tbl ret 30x100mg | SLO | SK |
| 46976 | SLOVALGIN 100 RETARD | tbl ret 60x100mg | SLO | SK |
| 55945 | M-ESLON SR 100 | cps ret 50x100mg | ETP | F |
| 55946 | M-ESLON SR 100 | cps ret 100x100mg | ETP | F |
| 80408 | VENDAL RETARD | tbl fc 30x100mg | LAR | D |
| 88842 | M-ESLON SR 100 | cps ret 20x100mg | ETP | F |
| 94312 | MST CONTINUS | tbl 60x100mg | NPP | GB |
| 368.4 | N02AA01 | morfin (nad 30 mg do 99 mg včetně v jedné tabletě) | p.o. | 0.1 | GM | 50,39 |
| 46977 | SLOVALGIN 60 RETARD | tbl ret 30x60mg | SLO | SK |
| 46978 | SLOVALGIN 60 RETARD | tbl ret 60x60mg | SLO | SK |
| 55943 | M-ESLON SR 60 | cps ret 50x60mg | ETP | F |
| 55944 | M-ESLON SR 60 | cps ret 100x60mg | ETP | F |
| 80407 | VENDAL RETARD | tbl fc 30x60mg | LAR | D |
| 88839 | M-ESLON SR 60 | cps ret 20x60mg | ETP | F |
| 94311 | MST CONTINUS | tbl 60x60mg | NPP | GB |
| 368.5 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, do 30 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 61,60 | |
| 368.6 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, nad 30 mg do 99 mg v jedné dávce včetně) | p.o. | 0.1 | GM | 58,36 | |
| 368.7 | N02AA01 | morfin (tekuté lékové formy s retardovaným uvolňováním, 100 a více mg v jedné dávce) | p.o. | 0.1 | GM | 53,90 | |
| 368.8 | N02AA01 | morfin (tekuté lékové formy, do 200 mg včetně v jednom balení) | p.o. | 0.1 | GM | 39,10 | |
| 368.9 | N02AA01 | morfin (tekuté lékové formy, nad 200 mg v jednom balení) | p.o. | 0.1 | GM | 17,60 | |
| 368.10 | N02AA05 | oxycodon do 20 mg v jedné tabletě včetně | p.o. | 30 | MG | 57,20 | |
| 368.11 | N02AA05 | oxycodon více než 20 mg do 40 mg v jedné tabletě včetně | p.o. | 30 | MG | 52,64 | |
| 368.12 | N02AA05 | oxycodon více než 40 mg v jedné tabletě | p.o. | 30 | MG | 48,74 | |
| 368.13 | N02AA08 | dihydrocodein (do 90 mg v jedné tabletě včetně) | p.o. | 0.24 | GM | 52,34 | |
| 80451 | DHC CONTINUS 60MG | tbl 56x60mg | NPP | GB |
| 56873 | DHC CONTINUS 60MG | tbl ret 20x60mg | NPP | GB |
| 56874 | DHC CONTINUS 90MG | tbl ret 20x90mg | NPP | GB |
| 368.14 | N02AA08 | dihydrocodein (nad 90 mg v jedné tabletě) | p.o. | 0.24 | GM | 44,58 |
| 369 | N02AA | analgetika ze skupiny přírodních opioidů | parent. | O |
| 369.1 | N02AA01 | morfin (do 10 mg v jedné ampuli včetně) | parent. | 30 | MG | 15,42 | O |
| 01125 | MORPHIN BIOTIKA 1% | inj 10x1ml/10mg | HBS | SK |
| 369.2 | N02AA01 | morfin (nad 10 mg v jedné ampuli) | parent. | 30 | MG | 9,32 | O |
| 01127 | MORPHIN BIOTIKA 1% | inj 10x2ml/20mg | HBS | SK |
| 370 | N02AB | analgetika ze skupiny fenylpiperidinových derivátů | p.o. |
| 370.1 | N02AB02 | pethidin | p.o. | 0.4 | GM | 41,30 | |
| 370.2 | N02AB03 | fentanyl (s řízeným uvolňováním 25 mikrogramu za hodinu) | transd. | 1 | DF | 241,46 | P |
| 370.3 | N02AB03 | fentanyl (s řízeným uvolňováním 50 mikrogramu za hodinu) | transd. | 1 | DF | 458,80 | P |
| 370.4 | N02AB03 | fentanyl (s řízeným uvolňováním 75 mikrogramu za hodinu) | transd. | 1 | DF | 667,20 | P |
| 370.5 | N02AB03 | fentanyl (s řízeným uvolňováním 100 mikrogramu za hodinu) | transd. | 1 | DF | 807,50 | P |
Lék je indikován v případě, kdy jiné opiody nejsou pro pacienta vhodné.
Následující stránka